Current progress has indicated that AQP3 may act an important target for the disorders that involve disruption of intestinal fluid homeostasis (as summarized in Figure 2, created with BioRender.com), such as diarrhea, constipation, inflammatory bowel disease, and irritable bowel syndrome. This evidence concerns the gene AQP3 and Constipation.